CKPT — Checkpoint Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $345.11m
- $338.50m
- $0.04m
Annual cashflow statement for Checkpoint Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -23.1 | -56.7 | -62.6 | -51.8 | -56.2 |
| Non-Cash Items | 8.3 | 10.8 | 9.68 | 7.05 | 24 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.77 | 19.6 | -4.61 | -2.79 | 1.18 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -16.6 | -26.3 | -57.6 | -47.6 | -31.1 |
| Financing Cash Flow Items | -2.03 | -1.01 | -1.95 | -4.3 | -2.41 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 31.2 | 40.3 | 14.9 | 40.5 | 32.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 14.7 | 14 | -42.7 | -7.14 | 1.68 |